A phase II study of temsirolimus (CCI-779) in patients with metastatic and/or locally recurrent endometrial cancer - NCICCTG IND 160. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Oza, AM
  • Elit, Laurie
  • Biagi, J
  • Gotlieb, W
  • Tonkin, KS
  • Tsao, M
  • Hedley, D
  • Hansen, C
  • Dancey, J
  • Eisenhauer, E
  • Seymour, L

publication date

  • December 15, 2005